FDA.reportPublic FDA data

POTASSIUM HYDROXIDE

Substance profile for UNII WZH3C48M4T, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for POTASSIUM HYDROXIDE
Structure render from PubChem CID 14797

Substance Identity#

UNII
WZH3C48M4T
Preferred term
POTASSIUM HYDROXIDE
Registry number
1310-58-3
EC number
215-181-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
K.HO
Chemical structure for POTASSIUM HYDROXIDE
Structure render from PubChem CID 14797

Chemical And Database Identifiers#

InChIKey
KWYUFKZDYYNOTN-UHFFFAOYSA-M
SMILES
[OH-].[K+]
RxCUI
34311
PubChem
14797
NCIt
C28204
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound14797https://pubchem.ncbi.nlm.nih.gov/compound/14797
PubChem InChIKey SearchKWYUFKZDYYNOTN-UHFFFAOYSA-Mhttps://pubchem.ncbi.nlm.nih.gov/#query=KWYUFKZDYYNOTN-UHFFFAOYSA-M
RxNorm34311https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=34311
NCI ThesaurusC28204https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28204
FDA Substance Registration SystemWZH3C48M4Thttps://precision.fda.gov/uniisearch/srs/unii/WZH3C48M4T
European Community number215-181-3https://commonchemistry.cas.org/results?q=215-181-3

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TLANSOPRAZOLE7
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TCefadroxil Capsules USP 500 mg2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4T104fea5c-cb2a-16c3-e054-00144ff88e882
potassium hydroxideINACTIVE INGREDIENTWZH3C48M4TTEMAZEPAM1
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TGABAPENTIN2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TIndomethacin Capsules USP, 25 mg and 50 mg5
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TEcosom Shampoo4
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TIndomethacin Extended – Release Capsules, USP 75 mg5
Potassium HydroxideINACTIVE INGREDIENTWZH3C48M4TEcosom Tonic2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4Tc635af0d-b005-4bce-8c43-24d0508c28ad5
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TThese highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19894
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TThese highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP. OMEPRAZOLE Delayed-Release Capsules, USP, for oral use INITIAL U.S. APPROVAL: 19892
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TThese highlights do not include all the information needed to use fluoxetine capsules safely and effectively. See full prescribing information for fluoxetine capsules. FLUOXETINE capsules, USP for oral use Initial U.S. Approval: 19873
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TFace Factor2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TThese highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP . OMEPRAZOLE Delayed-Release Capsules, USP , for oral use INITIAL U.S. APPROVAL: 198915
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TNantong Health & Beyond Green Soap2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TVENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES USP 7384 7385 7386 Rx only7
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TMaximum Strength Stomach Relief Liquid1
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4Tcd372f24-7f6c-46d0-86f3-ba8cfbebdff52
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TDynarex Green3
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TCEPHALEXIN CAPSULES USP2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TWell at Walgreens Oil-Free Daily Face Wash BONUS1
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TThese highlights do not include all the information needed to use duloxetine delayed-release capsules USP safely and effectively. See full prescribing information for duloxetine delayed-release capsules USP. DULOXETINE delayed-release capsules USP for oral use Initial U.S. Approval: 20042
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TThese highlights do not include all the information needed to use fluoxetine capsules, USP safely and effectively. See full prescribing information for fluoxetine capsules, USP. FLUOXETINE Capsules, USP for Oral Use Initial U.S. Approval: 19874
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TThese highlights do not include all the information needed to use amlodipine besylate and benazepril hydrochloride capsules safely and effectively. See full prescribing information for amlodipine besylate and benazepril hydrochloride capsules. AMLODIPINE besylate and BENAZEPRIL hydrochloride capsules for oral use Initial U.S. Approval: 19951000
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4Tf1f051d8-b8d8-4afd-84d8-82a59d9fa4fb1
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4T8d28ec4c-429b-4a2d-8ed5-f572db6c330c5
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TThese highlights do not include all the information needed to use Duloxetine Delayed-release Capsules safely and effectively. See full prescribing information for Duloxetine Delayed-release Capsules. DULOXETINE delayed-release capsules USP for oral use. Initial U.S. Approval: 20042
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4T61f1d07a-f5e9-45b5-8806-b31a441bc5924
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TThese highlights do not include all the information needed to use fluoxetine capsules, USP safely and effectively. See full prescribing information for fluoxetine capsules, USP. FLUOXETINE Capsules, USP for Oral Use Initial U.S. Approval: 198715
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TQuick Relief Diaper Rash Cream1
potassium hydroxideINACTIVE INGREDIENTWZH3C48M4TMiconazole 32
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TDrug Facts2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TLithium Carbonate Capsules USP1
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TGABAPENTIN CAPSULES, USP Rx only5
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TThese highlights do not include all the information needed to use LYRICA safely and effectively. See full prescribing information for LYRICA. LYRICA (pregabalin) Capsules, CV LYRICA (pregabalin) Oral Solution, CV Initial U.S. Approval: 20044
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TThese highlights do not include all the information needed to use Omeprazole safely and effectively. See full prescribing information for Omeprazole. Omeprazole (Omeprazole) CAPSULE for ORAL use. Initial U.S. Approval: 20133
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TGabapentin Capsules, USP 100 mg, 300 mg and 400 mg2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4T8e36c36f-aa9e-4ae2-8dea-53d167e81a7f6
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TNo7 Lift and Luminate Foundation Sunscreen Broad Spectrum SPF15 Toffee2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TNo7 Lift and Luminate Foundation Sunscreen Broad Spectrum SPF15 Hazelnut2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TThese highlights do not include all the information needed to use ziprasidone hydrochloride capsules safely and effectively. See full prescribing information for ziprasidone hydrochloride capsules. Ziprasidone Hydrochloride Capsules Initial U.S. Approval: 20014
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TThese highlights do not include all the information needed to use ziprasidone safely and effectively. See full prescribing information for ziprasidone. Ziprasidone Hydrochloride Capsules for Oral use Initial U.S. Approval: 20013
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4T2226151
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TThese highlights do not include all the information needed to use LYRICA safely and effectively. See full prescribing information for LYRICA. LYRICA (pregabalin) Capsules, CV LYRICA (pregabalin) Oral Solution, CV Initial U.S. Approval: 20042
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TDrug Facts2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TCEPHALEXIN CAPSULES USP2
Potassium HydroxideINACTIVE INGREDIENTWZH3C48M4TMonistat ® 1 Combination Pack2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TVENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES 7384 7385 7386 Rx only6
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4Tc9457679-ce84-40f1-8897-4db1e7a7de7c3
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4Tddaa5c2d-fefa-4da3-987c-a363e85a440d2
potassium hydroxideINACTIVE INGREDIENTWZH3C48M4TNo7 Protect and Perfect Intense Day Sunscreen Broad Spectrum SPF 15 - Skincare System2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TNo7 Beautifully Matte Foundation Mocha2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TNo7 L and L Foundation Cool Vanilla3
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TNo7 L and L Foundation Deeply Beige3
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TNo7 L and L Foundation Cool Beige2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TNo7 L and L Foundation Cool Ivory2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TNo7 L and L Foundation Ebony2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TNo7 L and L Foundation Mocha2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TNo7 L and L Foundation Wheat2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4T01ad8667-972c-4281-97ad-b087c7e58ab62
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4Tf279f873-26c1-48eb-bf86-6d0f995b3be81
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4Teeea080a-9655-44c8-9414-9ff9e013aa2b1
Potassium HydroxideINACTIVE INGREDIENTWZH3C48M4TUdder Essence BETTER BALM Medicated1
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TCEPHALEXIN CAPSULES USP2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TTemazepam Capsules, USP Novel Laboratories, Inc. Rx only4
Potassium HydroxideINACTIVE INGREDIENTWZH3C48M4TMONISTAT® 3 COMBINATION PACK2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TCarton and jar labelling4
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TVaseline Petroleum Jelly Cream Deep Moisture PDP and drug facts2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TCarton and jar labelling2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TLIGHT THE WAY5
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TDRUG FACTS1
potassium hydroxideINACTIVE INGREDIENTWZH3C48M4T2ed81194-be24-45a0-8dde-fbc6ad3d7abe4
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TCLINDAMYCIN HYDROCHLORIDE CAPSULES, USP Rx only2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TThese highlights do not include all the information needed to use Amlodipine Besylate and Benazepril Hydrochloride Capsules safely and effectively. See full prescribing information for Amlodipine Besylate and Benazepril Hydrochloride Capsules. Amlodipine Besylate and Benazepril Hydrochloride Capsules Initial U.S. Approval: 19955
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TIsradipine Capsules, USP3
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TThese highlights do not include all the information needed to use LYRICA safely and effectively. See full prescribing information for LYRICA. LYRICA (pregabalin) Capsules, CV LYRICA (pregabalin) Oral Solution, CV Initial U.S. Approval: 20045
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TFULL PRESCRIBING INFORMATION These highlights do not include all the information needed to use OMEPRAZOLE DELAYED-RELEASE safely and effectively. See full prescribing information for OMEPRAZOLE DELAYED-RELEASE. OMEPRAZOLE DELAYED-RELEASE (omeprazole) capsule, delayed release for oral use Initial U.S. Approval: 19893
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TAmoxicillin Capsules, Tablets and Powder for Oral Suspension, USP6
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TCEPHALEXIN CAPSULES USP3
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TCefadroxil Capsules USP 500 mg2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TCLINDAMYCIN HYDROCHLORIDE CAPSULES, USP Rx only2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TIndomethacin Capsules USP, 25 mg and 50 mg3
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TThese highlights do not include all the information needed to use lansoprazole delayed-release capsules USP safely and effectively. See full prescribing information for lansoprazole delayed-release capsules USP. LANSOPRAZOLE delayed-release capsules USP for oral use Initial U.S. Approval: 19954
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TLithium Carbonate Capsules USP Rx Only6
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TThese highlights do not include all the information needed to use LYRICA safely and effectively. See full prescribing information for LYRICA. LYRICA (pregabalin) Capsules, CV LYRICA (pregabalin) Oral Solution, CV Initial U.S. Approval: 20044
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TThese highlights do not include all the information needed to use tamsulosin hydrochloride capsules safely and effectively. See full prescribing information for tamsulosin hydrochloride capsules. Tamsulosin Hydrochloride Capsules, 0.4 mg Initial U.S. Approval: 19973
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4Tba5c415e-2a44-4b49-b85a-55984e3131b83
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TStrazepam17
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TThese highlights do not include all the information needed to use tamsulosin hydrochloride safely and effectively. See full prescribing information for tamsulosin hydrochloride. Tamsulosin Hydrochloride Capsules USP*, 0.4 mg Initial U.S. Approval: 19971
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TCephalexin Capsule2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TCEPHALEXIN CAPSULES USP2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TIndomethacin Capsules USP, 25 mg2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TEverflex Topical Analgesic Pain Relief Cream3
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TLithium Carbonate Capsules USP Rx Only4
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TLithium Carbonate Capsules USP Rx Only2
Potassium HydroxideINACTIVE INGREDIENTWZH3C48M4TCarton and tube labelling2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TThese highlights do not include all the information needed to use risperidone oral solution safely and effectively. See full prescribing information for risperidone oral solution. Risperidone Oral Solution for Oral use. Initial U.S. approval:19931
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TCarton and jar labelling6
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TDrug Facts2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TLithium Carbonate Capsules USP 150 mg, 300 mg and 600 mg2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TDrug Facts2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TDRUG FACTS3
Potassium HydroxideINACTIVE INGREDIENTWZH3C48M4TDrug Facts2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TLithium Carbonate Capsules USP 150 mg, 300 mg and 600 mg2
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TCarton and jar labelling4
Potassium HydroxideINACTIVE INGREDIENTWZH3C48M4TCarton and tube labelling1
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TCarton and jar labelling2
Potassium HydroxideINACTIVE INGREDIENTWZH3C48M4TCarton and tube labelling1
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TCarton and jar labels4
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TCarton and jar labels2
potassium hydroxideINACTIVE INGREDIENTWZH3C48M4TISMOTIC® (isosorbide solution) 45% w/v Solution1
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TLYRICA (PREGABALIN) CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY, DBA QUALITY CARE PRODUCTS, LLC]3996
potassium hydroxideINACTIVE INGREDIENTWZH3C48M4TTEMAZEPAM CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3945
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TINDOMETHACIN CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3911
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TLYRICA (PREGABALIN) CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3671
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TLYRICA (PREGABALIN) CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3544
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TLYRICA (PREGABALIN) CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3535
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TLYRICA (PREGABALIN) CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3363
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TLYRICA (PREGABALIN) CAPSULE [LAKE ERIE MEDICAL SURGICAL & SUPPLY DBA QUALITY CARE PRODUCTS LLC]3362